Page last updated: 2024-10-31

metoclopramide and Alzheimer Disease

metoclopramide has been researched along with Alzheimer Disease in 3 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Research Excerpts

ExcerptRelevanceReference
"Patients with Alzheimer's disease released AVP normally after hypotension."1.27Alterations in vasopressin regulation in Alzheimer's disease. ( Bertora, P; Bevilacqua, M; Carella, F; Chebat, E; Grassi, MP; Mangoni, A; Norbiato, G; Raggi, U, 1988)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, S1
Seeman, P1
Liu, F1
Franceschi, M1
Perego, L1
Ferini-Strambi, L1
Smirne, S1
Canal, N1
Norbiato, G1
Bevilacqua, M1
Carella, F1
Chebat, E1
Raggi, U1
Bertora, P1
Grassi, MP1
Mangoni, A1

Other Studies

3 other studies available for metoclopramide and Alzheimer Disease

ArticleYear
Antipsychotic drug binding in the substantia nigra: an examination of high metoclopramide binding in the brains of normal, Alzheimer's disease, Huntington's disease, and Multiple Sclerosis patients, and its relation to tardive dyskinesia.
    Synapse (New York, N.Y.), 2011, Volume: 65, Issue:2

    Topics: Alzheimer Disease; Animals; Antipsychotic Agents; Dopamine Antagonists; Dose-Response Relationship,

2011
Neuroendocrinological function in Alzheimer's disease.
    Neuroendocrinology, 1988, Volume: 48, Issue:4

    Topics: Aged; Alzheimer Disease; beta-Endorphin; beta-Lipotropin; Female; Growth Hormone; Humans; Male; Meto

1988
Alterations in vasopressin regulation in Alzheimer's disease.
    Journal of neurology, neurosurgery, and psychiatry, 1988, Volume: 51, Issue:7

    Topics: Aged; Alzheimer Disease; Arginine Vasopressin; Blood Pressure; Female; Humans; Hypothalamus; Male; M

1988